Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains

International Journal of Antimicrobial Agents

Volumn 40, Issue 6, 2012, Pages 527-532

  Cencig, Sabrina ^a   Coltel, Nicolas ^a   Truyens, Carine ^a   Carlier, Yves ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

AmBisome ; Benznidazole; Cure; Nifurtimox; Posaconazole; Trypanosoma cruzi

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; BENZNIDAZOLE; CYCLOPHOSPHAMIDE; NIFURTIMOX; POSACONAZOLE; PROTOZOAL DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD EXAMINATION; CHAGAS DISEASE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DNA DETERMINATION; DRUG EFFICACY; DRUG SENSITIVITY; GENETIC STRAIN; GENOTYPE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MICROSCOPY; MOUSE; NONHUMAN; PARASITE EXAMINATION; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT DURATION; TREATMENT RESPONSE; TRYPANOSOMA CRUZI;

AMPHOTERICIN B; ANIMALS; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; DNA, PROTOZOAN; DRUG THERAPY, COMBINATION; FEMALE; MICE; MICE, INBRED BALB C; NIFURTIMOX; NITROIMIDAZOLES; PARASITE LOAD; PARASITEMIA; REAL-TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TRIAZOLES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 84869507989     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.08.002     Document Type: Article

References (30)

1. A. Rassi Jr., A. Rassi, and J.A. Marin-Neto Chagas disease Lancet 375 2010 1388 1402
2. J.R. Coura, and P.A. Viñas Chagas disease: a new worldwide challenge Nature 465 2010 S6 S7
3. Y. Carlier, F. Torrico, S. Sosa-Estani, G. Russomando, A. Luquetti, and H. Freilij Congenital Chagas disease: recommendations for diagnosis, treatment and control of newborns, siblings and pregnant women PLoS Negl Trop Dis 5 2011 e1250
4. J.A. Urbina Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches Acta Trop 115 2010 55 68
5. R. Viotti, C. Vigliano, B. Lococo, G. Bertocchi, M. Petti, and M.G. Alvarez Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial Ann Intern Med 144 2006 724 734 (Pubitemid 46780632)
6. L.S. Filardi, and Z. Brener Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease Trans R Soc Trop Med Hyg 81 1987 755 759 (Pubitemid 18070985)
7. R.A. Neal, and J. van Bueren Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi in vivo and in vitro Trans R Soc Trop Med Hyg 82 1988 709 714
8. Y. Jackson, E. Alirol, L. Getaz, H. Wolff, C. Combescure, and F. Chappuis Tolerance and safety of nifurtimox in patients with chronic Chagas disease Clin Infect Dis 51 2010 e69 e75
9. R. Viotti, C. Vigliano, B. Lococo, M.G. Alvarez, M. Petti, and G. Bertocchi Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities Expert Rev Anti Infect Ther 7 2009 157 163
10. I. Ribeiro, A.M. Sevcsik, F. Alves, G. Diap, R. Don, and M.O. Harhay New, improved treatments for Chagas disease: from the R&D pipeline to the patients PLoS Negl Trop Dis 3 2009 e484
11. J.A. Urbina Ergosterol biosynthesis and drug development for Chagas disease Mem Inst Oswaldo Cruz 104 Suppl. 1 2009 311 318
12. B.P. Olivieri, J.T. Molina, S.L. de Castro, M.C. Pereira, C.M. Calvet, and J.A. Urbina A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease Int J Antimicrob Agents 36 2010 79 83
13. S. Cencig, N. Coltel, C. Truyens, and Y. Carlier Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome PLoS Negl Trop Dis 5 2011 e1216
14. V. Yardley, and S.L. Croft In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections Am J Trop Med Hyg 61 1999 193 197 (Pubitemid 29380248)
15. M.S. Araújo, O.A. Martins-Filho, M.E. Pereira, and Z. Brener A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease J Antimicrob Chemother 45 2000 819 824 (Pubitemid 30348953)
16. G. Batista Dda, M.M. Batista, G.M. de Oliveira, C.C. Britto, A.C. Rodrigues, and C.E. Stephens Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo PLoS One 6 2011 e22155
17. M. Faúndez, R. López-Muñoz, G. Torres, A. Morello, J. Ferreira, and U. Kemmerling Buthionine sulfoximine has anti-Trypanosoma cruzi activity in a murine model of acute Chagas' disease and enhances the efficacy of nifurtimox Antimicrob Agents Chemother 52 2008 1837 1839 (Pubitemid 351614681)
18. P. Gobbi, A. Baez, M.S. Lo Presti, A.R. Fernández, J.E. Enders, and R. Fretes Association of clomipramine and allopurinol for the treatment of the experimental infection with Trypanosoma cruzi Parasitol Res 107 2010 1279 1283
19. L.G. Oliveira, C.C. Kuehn, C.D. Santos, M.P. Toldo, and J.C. do Prado Jr. Enhanced protection by melatonin and meloxicam combination in experimental infection by Trypanosoma cruzi Parasite Immunol 32 2010 245 251
20. R.H. Valdez, L.T. Tonin, T. Ueda-Nakamura, S.O. Silva, B.P. Dias Filho, and E.N. Kaneshima In vitro and in vivo trypanocidal synergistic activity of N-butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro-β-carboline-3- carboxamide associated with benznidazole Antimicrob Agents Chemother 56 2012 507 512
21. G. Benaim, J.M. Sanders, Y. Garcia-Marchan, C. Colina, R. Lira, and A.R. Caldera Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole J Med Chem 49 2006 892 899 (Pubitemid 43221637)
22. Y. Carlier, M.T. Rivera, C. Truyens, M. Goldman, P. Lambert, and J. Flament Pregnancy and humoral immune response in mice chronically infected by Trypanosoma cruzi Infect Immun 55 1987 2496 2501 (Pubitemid 17132555)
23. J.M. Bustamante, L.M. Bixby, and R.L. Tarleton Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease Nat Med 14 2008 542 550 (Pubitemid 351655210)
24. K.L. Cummings, and R.L. Tarleton Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR Mol Biochem Parasitol 129 2003 53 59 (Pubitemid 36703222)
25. J. Molina, O. Martins-Filho, Z. Brener, A.J. Romanha, D. Loebenberg, and J.A. Urbina Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts Antimicrob Agents Chemother 44 2000 150 155 (Pubitemid 30010686)
26. A. Moton, G. Krishna, and Z. Wang Tolerability and safety profile of posaconazole: evaluation of 18 controlled studies in healthy volunteers J Clin Pharm Ther 34 2009 301 311
27. B.S. Hall, and S.R. Wilkinson Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation Antimicrob Agents Chemother 56 2012 115 123
28. S.R. Wilkinson, C. Bot, J.M. Kelly, and B.S. Hall Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives Curr Top Med Chem 11 2011 2072 2084
29. Z. Brener, J.R. Cancado, L.M. Galvao, Z.M. da Luz, L.S. Filardi, and M.E. Pereira An experimental and clinical assay with ketoconazole in the treatment of Chagas disease Mem Inst Oswaldo Cruz 88 1993 149 153
30. M.P. Cabeza, J.G. Chambo, and R.P. Laguens Differences in resistance to reinfection with low and high inocula of Trypanosoma cruzi in chagasic mice treated with nifurtimox and relation to immune response Antimicrob Agents Chemother 32 1988 241 245 (Pubitemid 18061382)